CRMD logo

CRMD
CorMedix Inc

23,418
Mkt Cap
$530.43M
Volume
622.00
52W High
$17.43
52W Low
$5.60
PE Ratio
3.38
CRMD Fundamentals
Price
$6.71
Prev Close
$6.70
Open
$6.78
50D MA
$7.09
Beta
1.06
Avg. Volume
1.62M
EPS (Annual)
$2.03
P/B
1.31
Rev/Employee
$1.63M
$933.71
Loading...
Loading...
News
all
press releases
Do Options Traders Know Something About CorMedix Stock We Don't?
Investors need to pay close attention to CRMD stock based on the movements in the options market lately.
Zacks·4d ago
News Placeholder
More News
News Placeholder
CorMedix (CRMD) Expected to Announce Earnings on Tuesday
CorMedix (NASDAQ:CRMD) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 31. (View Earnings Report at...
MarketBeat·6d ago
News Placeholder
CorMedix Inc (NASDAQ:CRMD) Given Consensus Rating of "Moderate Buy" by Brokerages
CorMedix Inc (NASDAQ:CRMD - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eight research firms that are currently covering the stock, Marketbeat.com reports. One...
MarketBeat·13d ago
News Placeholder
CorMedix Inc $CRMD Shares Bought by Divisadero Street Capital Management LP
Divisadero Street Capital Management LP boosted its holdings in shares of CorMedix Inc (NASDAQ:CRMD - Free Report) by 305.7% during the third quarter, according to its most recent disclosure with the...
MarketBeat·14d ago
News Placeholder
CorMedix CEO touts Melinta pivot, DefenCath TDAPA transition and Q2 REZZAYO Phase 3 data at Leerink
CorMedix (NASDAQ:CRMD) Chief Executive Officer Joseph Todisco told attendees at the Leerink Global Healthcare Conference that the company has undergone a significant shift over the last year, moving...
MarketBeat·15d ago
News Placeholder
CorMedix Touts Q2 REZZAYO Data, Melinta Integration and DefenCath Reimbursement Shift at Conference
CorMedix (NASDAQ:CRMD) executives used a presentation at the Citizens Life Sciences Conference to outline the company's focus on expanding its pipeline while integrating the recently acquired Melinta...
MarketBeat·15d ago
News Placeholder
HC Wainwright Issues Negative Estimate for CorMedix Earnings
CorMedix Inc (NASDAQ:CRMD - Free Report) - Stock analysts at HC Wainwright dropped their Q1 2026 earnings per share estimates for shares of CorMedix in a research report issued to clients and...
MarketBeat·21d ago
News Placeholder
Needham & Company LLC Lowers CorMedix (NASDAQ:CRMD) Price Target to $14.00
Needham & Company LLC dropped their target price on shares of CorMedix from $15.00 to $14.00 and set a "buy" rating for the company in a research report on Thursday...
MarketBeat·24d ago
News Placeholder
CorMedix Q4 Earnings Call Highlights
CorMedix (NASDAQ:CRMD) executives said 2025 was a transformational year, highlighted by DefenCath reaching peak sales of just under $260 million, the acquisition of Melinta Therapeutics, and the...
MarketBeat·24d ago
News Placeholder
Broadcom & OpenAI Partnership? AI Stocks Explode While Dow Drips! 🚀
Broadcom & OpenAI Partnership? AI Stocks Explode While Dow Drips! 🚀 $QQQ, $SPY, $IWM, $DIA, $AVGO, $TTD, $CRMD, $AMPX, $PDYN, $COST Is the AI trade officially back? In today’s market breakdown, we’re diving into the massive AI-driven surges from Broadcom ($AVGO) and The Trade Desk ($TTD), even as the Dow struggles to hold 50k and geopolitical tensions rise. From OpenAI’s secret custom chip plans to a potential ChatGPT ad-tech integration, the retail crowd is piling into the next wave of tech giants. Earnings Watch: What to expect from Costco ($COST) tonight. Stay ahead of the tape! Subscribe to The Daily Rip for the fastest stock moves delivered straight to your inbox every morning: thedailyrip.stocktwits.com
Stocktwits·25d ago
<
1
2
...
>

Latest CRMD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.